Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Drops By 40.6%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 44,700 shares, a decline of 40.6% from the August 15th total of 75,200 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 308,800 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 308,800 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised China SXT Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Saturday, August 2nd.

China SXT Pharmaceuticals Trading Down 7.1%

SXTC stock traded down $0.14 during mid-day trading on Monday, hitting $1.84. The company had a trading volume of 72,882 shares, compared to its average volume of 1,730,906. China SXT Pharmaceuticals has a 12 month low of $0.95 and a 12 month high of $7.84. The stock’s fifty day moving average price is $1.60 and its two-hundred day moving average price is $2.02. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.40 and a current ratio of 3.54.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.